T1	Participants 41 60	ovarian suppression
T2	Participants 132 215	depressive symptoms associated with ovarian suppression during GnRH agonist therapy
T3	Participants 436 630	Premenstrual women with laparoscopically diagnosed endometriosis who required GnRH agonist therapy for treatment and did not have significant depressive or premenstrual mood symptoms at baseline
T4	Participants 1356 1445	depressive mood symptoms associated with ovarian suppression during GnRH agonist therapy.
